News & AnalysisEvofem Biosciences inks $25mEvofem Biosciences Inc has secured $25 million in funding from Adjuvant Capital LP.ByIris Dorbian15 October 2020•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs